The VDRL Test is a widely used blood test to screen for syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. Rather than detecting the bacteria itself, the test identifies antibodies your body produces in response to the infection. A non-reactive (negative) result generally indicates no infection, while a reactive (positive) result suggests possible syphilis, which requires confirmation through more specific tests. This screening is especially important for individuals with STI symptoms, pregnant women, or those at risk due to unprotected sexual contact.

The VDRL test is affordable and accessible across India, with most diagnostic centers offering quick turnaround times—often within 24 hours. In addition to Apollo Hospital, Redcliffe Labs also provides widespread coverage and home sample collection services. Further, the test is also available at various hospital-based diagnostic centers and government health facilities such as AIIMS (All India Institute of Medical Sciences) and state-run health departments. These centers ensure reliable testing and make the service accessible to a broader population, contributing to early diagnosis and effective treatment.

Getting tested with the VDRL test is crucial because syphilis often shows no symptoms in its early stages but can lead to serious health complications if left untreated. Early detection through this simple test allows for timely treatment, preventing long-term damage and reducing the risk of spreading the infection to others, including unborn babies during pregnancy.